Kraig Biocraft Labs Stock Return On Equity
KBLB Stock | USD 0.09 0.0001 0.11% |
Kraig Biocraft Labs fundamentals help investors to digest information that contributes to Kraig Biocraft's financial success or failures. It also enables traders to predict the movement of Kraig OTC Stock. The fundamental analysis module provides a way to measure Kraig Biocraft's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kraig Biocraft otc stock.
Kraig |
Kraig Biocraft Labs OTC Stock Return On Equity Analysis
Kraig Biocraft's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Based on the latest financial disclosure, Kraig Biocraft Labs has a Return On Equity of 0.0. This is 100.0% lower than that of the Chemicals sector and 100.0% lower than that of the Materials industry. The return on equity for all United States stocks is 100.0% lower than that of the firm.
Kraig Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kraig Biocraft's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Kraig Biocraft could also be used in its relative valuation, which is a method of valuing Kraig Biocraft by comparing valuation metrics of similar companies.Kraig Biocraft is currently under evaluation in return on equity category among its peers.
Kraig Fundamentals
Return On Asset | -0.32 | |||
Current Valuation | 34.14 M | |||
Shares Outstanding | 1.02 B | |||
Shares Owned By Insiders | 25.29 % | |||
Shares Owned By Institutions | 0.01 % | |||
Price To Earning | (9.37) X | |||
Price To Sales | 1,199 X | |||
EBITDA | (2.64 M) | |||
Net Income | (8.05 M) | |||
Cash And Equivalents | 4.82 M | |||
Total Debt | 95.24 K | |||
Current Ratio | 0.53 X | |||
Book Value Per Share | (0.01) X | |||
Cash Flow From Operations | (1.8 M) | |||
Earnings Per Share | (0.01) X | |||
Number Of Employees | 38 | |||
Beta | 0.34 | |||
Market Capitalization | 38.03 M | |||
Total Asset | 3.02 M | |||
Retained Earnings | (22.47 M) | |||
Working Capital | (2.32 M) | |||
Current Asset | 356 K | |||
Current Liabilities | 2.68 M | |||
Net Asset | 3.02 M |
About Kraig Biocraft Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kraig Biocraft Labs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kraig Biocraft using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kraig Biocraft Labs based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Kraig OTC Stock
Kraig Biocraft financial ratios help investors to determine whether Kraig OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kraig with respect to the benefits of owning Kraig Biocraft security.